Newsbenzinga
AIM ImmunoTech Says Overall Survival Analysis In Phase 2 Pancreatic Cancer Trial To Begin In Q3 2027; Reiterates Q1 2027 Topline Data
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…